It has also been demonstrated that obesity upregulates the hepatic expressions of MsrB1, SELENON, SELENOP, and SELENOW, as well as GPx4 in diabetic patients by 33–35% compared to non-obese subjects [131]. Here, SELENOP is linked to obesity disorder.